<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Results</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Encounters</a></li><li><a href="#id5">Assessments</a></li><li><a href="#id6">Plan Of Treatment</a></li><li><a href="#id7">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">VITAMIN D, 1,25 DIHYDROXY (16558)</span><br/>Reviewed date:[REDACTED] 08:31:22 AM<br/>Interpretation:<br/>Performing Lab:AMD, Quest Diagnostics/[REDACTED] Chantilly-Chantilly VA14225 Newbrook Dr, ChantillyVA20151-2228 [REDACTED] M.D.,PhD<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result1_attr1">VITAMIN D, 1,25 (OH)2, TOTAL</td><td>45</td><td>18-72 pg/mL</td><td/></tr><tr><td ID="result1_attr2">VITAMIN D3, 1,25 (OH)2</td><td>45</td><td/><td/></tr><tr><td ID="result1_attr3">VITAMIN D2, 1,25 (OH)2</td><td>&lt;8</td><td/><td ID="result1_attr3_notes"><p/><p>Vitamin D3, 1,25(OH)2 indicates both endogenous</p><p>production and supplementation. Vitamin D2, 1,25(OH)2</p><p>is an indicator of exogenous sources, such as diet or</p><p>supplementation.  Interpretation and therapy are based</p><p>on measurement of Vitamin D,1,25(OH)2, Total.</p><p>This test was developed and its analytical</p><p>performance characteristics have been determined</p><p>by Quest Diagnostics [REDACTED] Institute, Chantilly, VA.</p><p>It has not been cleared or approved by the FDA. This</p><p>assay has been validated pursuant to the CLIA</p><p>regulations and is used for clinical purposes.</p></td></tr><tr><td colspan="4"><span class="content_span">TSH W/REFLEX TO FT4 (36127)</span><br/>Reviewed date:[REDACTED] 08:31:21 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result2_attr1">TSH W/REFLEX TO FT4</td><td>1.87</td><td>0.40-4.50 mIU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">VITAMIN B12/FOLATE, SERUM PANEL (7065)</span><br/>Reviewed date:[REDACTED] 08:31:21 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result3_attr1">VITAMIN B12</td><td>1630</td><td>200-1100 pg/mL</td><td/></tr><tr><td ID="result3_attr2">FOLATE, SERUM</td><td>17.5</td><td/><td ID="result3_attr2_notes"><p>                           Reference Range</p><p>                           Low:           &lt;3.4</p><p>                           Borderline:    3.4-5.4</p><p>                           Normal:        &gt;5.4</p></td></tr><tr><td colspan="4"><span class="content_span">URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020)</span><br/>Reviewed date:[REDACTED] 08:31:21 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result4_attr1">COLOR</td><td>YELLOW</td><td>YELLOW</td><td/></tr><tr><td ID="result4_attr2">APPEARANCE</td><td>CLEAR</td><td>CLEAR</td><td/></tr><tr><td ID="result4_attr3">SPECIFIC GRAVITY</td><td>1.012</td><td>1.001-1.035</td><td/></tr><tr><td ID="result4_attr4">PH</td><td>8.0</td><td>5.0-8.0</td><td/></tr><tr><td ID="result4_attr5">GLUCOSE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result4_attr6">BILIRUBIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result4_attr7">KETONES</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result4_attr8">OCCULT BLOOD</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result4_attr9">PROTEIN</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result4_attr10">NITRITE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result4_attr11">LEUKOCYTE ESTERASE</td><td>NEGATIVE</td><td>NEGATIVE</td><td/></tr><tr><td ID="result4_attr12">WBC</td><td>NONE SEEN</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result4_attr13">RBC</td><td>NONE SEEN</td><td>&lt; OR = 2 /HPF</td><td/></tr><tr><td ID="result4_attr14">SQUAMOUS EPITHELIAL CELLS</td><td>0-5</td><td>&lt; OR = 5 /HPF</td><td/></tr><tr><td ID="result4_attr15">BACTERIA</td><td>NONE SEEN</td><td>NONE SEEN /HPF</td><td/></tr><tr><td ID="result4_attr16">HYALINE CAST</td><td>NONE SEEN</td><td>NONE SEEN /LPF</td><td/></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:[REDACTED] 08:31:21 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result5_attr1">HEMOGLOBIN A1c</td><td>6.1</td><td>&lt;5.7 % of total Hgb</td><td ID="result5_attr1_notes"><p>For someone without known diabetes, a hemoglobin</p><p>follow-up test.</p><p>For someone with known diabetes, a value &lt;7%</p><p>indicates that their diabetes is well controlled. A1c</p><p>targets should be individualized based on duration of</p><p>diabetes, age, comorbid conditions, and other</p><p>considerations.</p><p>This assay result is consistent with an increased risk</p><p>of diabetes.</p><p>Currently, no consensus exists regarding use of</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p><p>This test was performed on the Roche cobas c503 platform.</p><p>Effective [REDACTED], a change in test platforms from the</p><p>[REDACTED] Architect to the Roche cobas c503 may have shifted</p><p>HbA1c results compared to historical results.</p><p>Based on laboratory validation testing conducted at</p><p>Quest, the Roche platform relative to the [REDACTED]</p><p>platform had an average increase in HbA1c value of</p><p>&lt; or = 0.3%. This difference is within accepted</p><p>variability established by the National Glycohemoglobin</p><p>A1c value between 5.7% and 6.4% is consistent with</p><p>prediabetes and should be confirmed with a</p><p>Standardization Program. Note that not all individuals</p><p>will have had a shift in their results and direct</p><p>comparisons between historical and current results for</p><p>testing conducted on different platforms is not</p><p>recommended.</p></td></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:[REDACTED] 08:31:21 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result6_attr1">WHITE BLOOD CELL COUNT</td><td>3.2</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result6_attr2">RED BLOOD CELL COUNT</td><td>4.27</td><td>3.80-5.10 Million/uL</td><td/></tr><tr><td ID="result6_attr3">HEMOGLOBIN</td><td>12.8</td><td>11.7-15.5 g/dL</td><td/></tr><tr><td ID="result6_attr4">HEMATOCRIT</td><td>40.2</td><td>35.0-45.0 %</td><td/></tr><tr><td ID="result6_attr5">MCV</td><td>94.1</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result6_attr6">MCH</td><td>30.0</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result6_attr7">MCHC</td><td>31.8</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result6_attr8">RDW</td><td>12.8</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result6_attr9">PLATELET COUNT</td><td>224</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result6_attr10">MPV</td><td>11.2</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result6_attr11">ABSOLUTE NEUTROPHILS</td><td>1728</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result6_attr12">ABSOLUTE LYMPHOCYTES</td><td>1078</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result6_attr13">ABSOLUTE MONOCYTES</td><td>346</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result6_attr14">ABSOLUTE EOSINOPHILS</td><td>29</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result6_attr15">ABSOLUTE BASOPHILS</td><td>19</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result6_attr16">NEUTROPHILS</td><td>54</td><td/><td/></tr><tr><td ID="result6_attr17">LYMPHOCYTES</td><td>33.7</td><td/><td/></tr><tr><td ID="result6_attr18">MONOCYTES</td><td>10.8</td><td/><td/></tr><tr><td ID="result6_attr19">EOSINOPHILS</td><td>0.9</td><td/><td/></tr><tr><td ID="result6_attr20">BASOPHILS</td><td>0.6</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 08:31:21 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 [REDACTED]<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result7_attr1">GLUCOSE</td><td>103</td><td>65-99 mg/dL</td><td ID="result7_attr1_notes"><p/><p>           Fasting reference interval</p><p>For someone without known diabetes, a glucose value</p><p>between 100 and 125 mg/dL is consistent with</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p></td></tr><tr><td ID="result7_attr2">UREA NITROGEN (BUN)</td><td>13</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result7_attr3">CREATININE</td><td>0.76</td><td>0.60-0.95 mg/dL</td><td/></tr><tr><td ID="result7_attr4">EGFR</td><td>78</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result7_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result7_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result7_attr6">SODIUM</td><td>140</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result7_attr7">POTASSIUM</td><td>4.1</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result7_attr8">CHLORIDE</td><td>102</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result7_attr9">CARBON DIOXIDE</td><td>32</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result7_attr10">CALCIUM</td><td>9.5</td><td>8.6-10.4 mg/dL</td><td/></tr><tr><td ID="result7_attr11">PROTEIN, TOTAL</td><td>6.5</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result7_attr12">ALBUMIN</td><td>4.0</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result7_attr13">GLOBULIN</td><td>2.5</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result7_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.6</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result7_attr15">BILIRUBIN, TOTAL</td><td>0.9</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result7_attr16">ALKALINE PHOSPHATASE</td><td>237</td><td>37-153 U/L</td><td/></tr><tr><td ID="result7_attr17">AST</td><td>22</td><td>10-35 U/L</td><td/></tr><tr><td ID="result7_attr18">ALT</td><td>17</td><td>6-29 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">LIPID PANEL W/REFL DIRECT LDL, CARDIO IQ(R) (92061)</span><br/>Reviewed date:[REDACTED] 08:31:21 AM<br/>Interpretation:<br/>Performing Lab:Z4M, Cleveland HeartLab Inc.-Cleveland HeartLab Inc.[REDACTED][REDACTED] [REDACTED] PhD,DABCC<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result8_attr1">CHOLESTEROL, TOTAL</td><td>215</td><td>&lt;200 mg/dL</td><td ID="result8_attr1_notes">Sample slightly hemolyzed.</td></tr><tr><td ID="result8_attr2">HDL CHOLESTEROL</td><td>84</td><td>&gt;49 mg/dL</td><td ID="result8_attr2_notes">Sample slightly hemolyzed.</td></tr><tr><td ID="result8_attr3">TRIGLYCERIDES</td><td>57</td><td>&lt;150 mg/dL</td><td ID="result8_attr3_notes">Sample slightly hemolyzed.</td></tr><tr><td ID="result8_attr4">LDL-CHOLESTEROL</td><td>117</td><td>&lt;100 mg/dL (calc)</td><td ID="result8_attr4_notes"><p>Desirable range &lt;100 mg/dL for primary prevention; &lt;70</p><p>mg/dL for patients with CHD or diabetic patients with &gt;= 2</p><p>CHD risk factors.</p><p>LDL-C is now calculated using the [REDACTED]</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-[REDACTED] SS et al. JAMA. 2013;310(19):</p><p>[REDACTED]-[REDACTED] (http://education.QuestDiagnostics.com/faq/FAQ164)</p><p>LDL-C is now calculated using the [REDACTED]</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-C.</p><p>[REDACTED] et al. JAMA. 2013;310(19): [REDACTED]-[REDACTED]</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p></td></tr><tr><td ID="result8_attr5">CHOL/HDLC RATIO</td><td>2.6</td><td>&lt;5.0 calc</td><td/></tr><tr><td ID="result8_attr6">NON HDL CHOLESTEROL</td><td>131</td><td>&lt;130 mg/dL (calc)</td><td ID="result8_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk factor,</p><p>treating to a non-HDL-C goal of &lt;100 mg/dL (LDL-C of &lt;70</p><p>mg/dL) is considered a therapeutic option.</p><p>For patients with diabetes plus 1 major ASCVD risk</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p></td></tr></tbody></table></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>BLOOD WORK</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Irbesartan 150 MG</td><td ID="instruction1"> Oral for 90 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Carbidopa-Levodopa 25-100 MG</td><td ID="instruction2">TAKE 2 TABLETS BY MOUTH FOUR TIMES DAILY Oral for 90 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">MiraLax 17 GM</td><td ID="instruction3">1 packet mixed with 8 ounces of fluid Orally Once a day for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication4">amLODIPine Besylate 5 MG</td><td ID="instruction4">TAKE 1 TABLET BY MOUTH EVERY DAY Oral for 90 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Atorvastatin Calcium 20 MG</td><td ID="instruction5"> Oral for 90 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Propranolol HCl ER 60 MG</td><td ID="instruction6">TAKE 1 CAPSULE BY MOUTH EVERY DAY Oral for 90 Days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM WPB [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Essential hypertension I10 ; [REDACTED] disease with dyskinesia and fluctuating manifestations G20.B2 ; Mixed hyperlipidemia E78.2 and BMI 23.0-23.9, adult Z68.23</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Essential hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>[REDACTED] disease with dyskinesia and fluctuating manifestations (ICD-10 - G20.B2)</td><td/><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>BMI 23.0-23.9, adult (ICD-10 - Z68.23)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED][REDACTED], [REDACTED] 10:00:00 AM, [REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>BROWN, TOTSIAN <span class="bold">DOB:</span> [REDACTED] ([REDACTED] F) <span class="bold">Acc No.</span> 812191 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>BROWN, TOTSIAN<br/><span class="bold">Account Number: </span>812191</td><td align="right"><span class="bold">Provider: </span>[REDACTED]-ARNP</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>82 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   BLOOD WORK</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingCarbidopa-Levodopa 25-100 MG Tablet TAKE 2 TABLETS BY MOUTH FOUR TIMES DAILY Oral  amLODIPine Besylate 5 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY Oral  Atorvastatin Calcium 20 MG Tablet  Oral  Irbesartan 150 MG Tablet  Oral  Propranolol HCl ER 60 MG Capsule Extended Release 24 Hour TAKE 1 CAPSULE BY MOUTH EVERY DAY Oral  MiraLax 17 GM Packet 1 packet mixed with 8 ounces of fluid Orally Once a day Taking Carbidopa-Levodopa 25-100 MG Tablet TAKE 2 TABLETS BY MOUTH FOUR TIMES DAILY Oral  Taking amLODIPine Besylate 5 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY Oral  Taking Atorvastatin Calcium 20 MG Tablet  Oral  Taking Irbesartan 150 MG Tablet  Oral  Taking Propranolol HCl ER 60 MG Capsule Extended Release 24 Hour TAKE 1 CAPSULE BY MOUTH EVERY DAY Oral  Taking MiraLax 17 GM Packet 1 packet mixed with 8 ounces of fluid Orally Once a day </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> </td></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Essential hypertension - I10 (Primary) 2. [REDACTED] disease with dyskinesia and fluctuating manifestations - G20.B2 3. Mixed hyperlipidemia - E78.2 4. BMI 23.0-23.9, adult - Z68.23 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Essential hypertension</span> <br/>     <span class="Underline">LAB: LIPID PANEL W/REFL DIRECT LDL, CARDIO IQ(R) (92061) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: VITAMIN D, 1,25 DIHYDROXY (16558) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span></td></tr><tr><td/></tr><tr><td><span class="bold">2. [REDACTED] disease with dyskinesia and fluctuating manifestations</span> <br/>     <span class="Underline">LAB: LIPID PANEL W/REFL DIRECT LDL, CARDIO IQ(R) (92061) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: VITAMIN D, 1,25 DIHYDROXY (16558) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span></td></tr><tr><td/></tr><tr><td><span class="bold">3. Mixed hyperlipidemia</span> <br/>     <span class="Underline">LAB: LIPID PANEL W/REFL DIRECT LDL, CARDIO IQ(R) (92061) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: VITAMIN D, 1,25 DIHYDROXY (16558) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span></td></tr><tr><td/></tr><tr><td><span class="bold">4. BMI 23.0-23.9, adult</span> <br/>     <span class="Underline">LAB: LIPID PANEL W/REFL DIRECT LDL, CARDIO IQ(R) (92061) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: URINALYSIS, COMPLETE W/REFLEX TO CULTURE (3020) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (496) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: VITAMIN B12/FOLATE, SERUM PANEL (7065) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (36127) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span><br/>     <span class="Underline">LAB: VITAMIN D, 1,25 DIHYDROXY (16558) (Collection Date &amp; Time - [REDACTED] 08:28 AM)</span></td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 36415 VENIPUNCT, ROUTINE*99000 SPECIMEN HANDLING</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>36415 VENIPUNCT, ROUTINE*. <br/>99000 SPECIMEN HANDLING. </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED]   on [REDACTED] 08:41 AM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED]-ARNP</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 12:40 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><br/><br/>
</body></html>